Motus GI Holdings, which is developing a medical device to assist with intraprocedural colonoscopy cleaning, filed on Friday with the SEC to raise up to $29 million in an initial public offering.
The Tirat Carmel, Israel-based company was founded in 2008 and plans to list on the Nasdaq under the symbol MOTS. Motus GI Holdings filed confidentially on April 12, 2017. Piper Jaffray and Oppenheimer & Co. are the joint bookrunners on the deal. No pricing terms were disclosed.
